Genprex Inc (GNPX)
2.21
+0.09
(+4.25%)
USD |
NASDAQ |
Apr 26, 16:00
2.10
-0.11
(-4.98%)
Pre-Market: 20:00
Genprex Price to Book Value: 0.5693 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 26, 2024 | 0.5693 |
April 25, 2024 | 0.5461 |
April 24, 2024 | 0.5693 |
April 23, 2024 | 0.595 |
April 22, 2024 | 0.5572 |
April 19, 2024 | 0.5487 |
April 18, 2024 | 0.5717 |
April 17, 2024 | 0.5693 |
April 16, 2024 | 0.5925 |
April 15, 2024 | 0.6053 |
April 12, 2024 | 0.6903 |
April 11, 2024 | 0.7161 |
April 10, 2024 | 0.7419 |
April 09, 2024 | 0.7908 |
April 08, 2024 | 0.7625 |
April 05, 2024 | 0.7728 |
April 04, 2024 | 0.7702 |
April 03, 2024 | 0.8011 |
April 02, 2024 | 0.7316 |
April 01, 2024 | 0.765 |
March 28, 2024 | 0.7676 |
March 27, 2024 | 0.6981 |
March 26, 2024 | 0.7058 |
March 25, 2024 | 0.7728 |
March 22, 2024 | 0.7882 |
Date | Value |
---|---|
March 21, 2024 | 0.7779 |
March 20, 2024 | 0.7013 |
March 19, 2024 | 0.7955 |
March 18, 2024 | 0.9626 |
March 15, 2024 | 0.8094 |
March 14, 2024 | 0.8335 |
March 13, 2024 | 0.8395 |
March 12, 2024 | 0.8435 |
March 11, 2024 | 0.9417 |
March 08, 2024 | 0.8475 |
March 07, 2024 | 0.8515 |
March 06, 2024 | 0.8775 |
March 05, 2024 | 0.8255 |
March 04, 2024 | 0.8495 |
March 01, 2024 | 0.8976 |
February 29, 2024 | 0.8615 |
February 28, 2024 | 0.8355 |
February 27, 2024 | 0.8415 |
February 26, 2024 | 0.8836 |
February 23, 2024 | 0.8735 |
February 22, 2024 | 0.8816 |
February 21, 2024 | 0.8996 |
February 20, 2024 | 0.8595 |
February 16, 2024 | 0.8816 |
February 15, 2024 | 0.8775 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5461
Minimum
Apr 25 2024
67.68
Maximum
Feb 25 2020
4.089
Average
2.678
Median
Sep 04 2019
Price to Book Value Benchmarks
Jaguar Health Inc | 10.42 |
FibroGen Inc | -- |
BioXcel Therapeutics Inc | -- |
TFF Pharmaceuticals Inc | 0.7693 |
4D Molecular Therapeutics Inc | 3.760 |
Price to Book Value Related Metrics
Price | 2.21 |
Earnings Yield | -1.02K% |
Market Cap | 4.222M |